Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $172.94 | 3 | 89.2% |
| Education | $21.00 | 1 | 10.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $149.26 | 2 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $23.68 | 1 | $0 (2024) |
| Mirati Therapeutics, Inc. | $21.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $172.94 | 3 | Janssen Biotech, Inc. ($149.26) |
| 2023 | $21.00 | 1 | Mirati Therapeutics, Inc. ($21.00) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $115.32 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $33.94 | General |
| Category: Oncology | ||||||
| 06/27/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Diabetes | ||||||
| 02/28/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 604 | 1,753 | $581,259 | $130,937 |
| 2022 | 5 | 579 | 1,576 | $443,132 | $118,330 |
| 2021 | 5 | 539 | 1,409 | $397,936 | $108,314 |
| 2020 | 6 | 490 | 1,329 | $394,651 | $88,011 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 336 | 1,326 | $395,938 | $98,205 | 24.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 71 | 71 | $26,981 | $9,926 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 133 | 213 | $40,959 | $9,878 | 24.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 101 | $25,048 | $9,434 | 37.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 18 | 19 | $7,391 | $2,133 | 28.9% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2023 | 21 | 23 | $84,942 | $1,361 | 1.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 310 | 1,156 | $342,544 | $88,344 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 165 | 260 | $49,230 | $13,024 | 26.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 69 | 69 | $26,358 | $9,863 | 37.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 75 | $18,600 | $6,116 | 32.9% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2022 | 15 | 16 | $6,400 | $983.89 | 15.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 282 | 1,061 | $314,534 | $83,487 | 26.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 164 | 247 | $47,555 | $12,724 | 26.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 66 | 66 | $25,212 | $9,448 | 37.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 22 | $5,435 | $1,835 | 33.8% |
| 38222 | Diagnostic aspirations and biopsies of bone marrow | Facility | 2021 | 13 | 13 | $5,200 | $820.69 | 15.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 259 | 1,014 | $309,270 | $65,289 | 21.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 64 | 64 | $24,448 | $8,653 | 35.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 122 | 178 | $34,532 | $7,256 | 21.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 20 | 47 | $11,656 | $3,764 | 32.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 13 | $5,941 | $2,208 | 37.2% |
| 38222 | Bone marrow biopsy and aspiration | Facility | 2020 | 13 | 13 | $8,804 | $841.76 | 9.6% |
About Dr. Sarah Scott, MD
Dr. Sarah Scott, MD is a Hematology & Oncology healthcare provider based in Missoula, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144335530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarah Scott, MD has received a total of $193.94 in payments from pharmaceutical and medical device companies, with $172.94 received in 2024. These payments were reported across 4 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($172.94).
As a Medicare-enrolled provider, Scott has provided services to 2,212 Medicare beneficiaries, totaling 6,067 services with total Medicare billing of $445,593. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Missoula, MT
- Active Since 08/19/2006
- Last Updated 05/20/2013
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1144335530
Products in Payments
- DARZALEX (Biological) $149.26
- GVOKE HYPOPEN (Drug) $23.68
- KRAZATI (Drug) $21.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Missoula
Alan Thomas, Md, MD
Hematology & Oncology — Payments: $2,008
Michael Snyder, Md, MD
Hematology & Oncology — Payments: $1,110
Patrick Beatty, Md, MD
Hematology & Oncology — Payments: $10.75
Linda Ries, Md, MD
Hematology & Oncology
Stephen Speckart, Md, MD
Hematology & Oncology
John Trauscht, Md, MD
Hematology & Oncology